These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9305659)

  • 1. Natural history of hepatitis C.
    Seeff LB
    Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
    Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
    Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical picture and evolution of hepatitis C].
    Marcellin P; Erlinger S
    Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
    Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
    Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and hepatocellular carcinoma.
    Di Bisceglie AM
    Hepatology; 1997 Sep; 26(3 Suppl 1):34S-38S. PubMed ID: 9305661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of hepatitis C as a function of mode of transmission.
    Gordon SC; Bayati N; Silverman AL
    Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection.
    Pokorski RJ
    J Insur Med; 2001; 33(1):12-36. PubMed ID: 11317876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for assessing the long-term consequences of Hepatitis C virus infection.
    Seeff LB
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):207-16. PubMed ID: 16501439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of hepatitis C: clinical experiences.
    Müller R
    J Hepatol; 1996; 24(2 Suppl):52-4. PubMed ID: 8836889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N; Marcellin P
    Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.
    Posthouwer D; Fischer K; van Erpecum KJ; Mauser-Bunschoten EP
    Transfusion; 2006 Aug; 46(8):1360-6. PubMed ID: 16934072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes after transfusion-associated hepatitis C.
    Tong MJ; el-Farra NS; Reikes AR; Co RL
    N Engl J Med; 1995 Jun; 332(22):1463-6. PubMed ID: 7739682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.
    Rerksuppaphol S; Hardikar W; Dore GJ
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1357-62. PubMed ID: 15610308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China].
    Fan WM; Zhu WF; Zhang SY; Wang QX; Yin LM; Wan H; Gao Y; Tian XL; Yu M; Jin J; Xu XY; Wei L; Zhuang H
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):392-6. PubMed ID: 15061992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.